-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2009 to 2024.
- Lifecore Biomedical, Inc. \De\ Weighted Average Number of Shares Outstanding, Diluted for the quarter ending May 25, 2025 was 34.8M shares, a 5.02% decline year-over-year.
- Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 34.8M shares, a 5.02% decline from 2023.
- Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 36.7M shares, a 22.4% increase from 2022.
- Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 30M shares, a 1.67% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)